Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Can-Fite Biopharma Ltd (NY: CANF )

2.380 USD -0.030 (-1.24%)
Official Closing Price Updated: 8:00 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 184,400
Open 2.390
Bid (Size) 2.360 (10)
Ask (Size) 2.400 (1)
Prev. Close 2.410
Today's Range 2.352 - 2.420
52wk Range 1.510 - 4.390
Shares Outstanding 19,981,145
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Can-Fite: Cannabis Compound Inhibits Liver Cancer Growth in Preclinical Studies
Can-Fite: Cannabis Compound Inhibits Liver Cancer Growth in Preclinical Studies 
From Business Wire News Releases
Can-Fite: Summary of Existing Out-licensing Deals with Potential Milestone Payments of up to approximately $130 million
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today... 
From Business Wire News Releases

Performance

YTD
+31.49%
+31.49%
1 Month
+17.82%
+17.82%
3 Month
+24.61%
+24.61%
6 Month
+31.49%
+31.49%
1 Year
+21.43%
+21.43%

More News

Read More
Can-Fite Reports 2020 Financial Results & Provides Clinical Development Update
From Business Wire News Releases
Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
From Business Wire News Releases
Can-Fite: Topical Administration of CF602 Fully Recovers Erectile Dysfunction in Diabetic Model
From Business Wire News Releases
Can-Fite Says Cannabinoid-Based Therapies Stop Liver Cancer Growth, Preclinical Studies Show
Tags Health Care General Liver Cancer
From Benzinga
The Market Slows Down As Q1 Closes Out
Tags ZCMD Market News CHEK
From Benzinga
Thinking about buying stock in Neos Therapeutics, Oriental Culture, Sino-Global Shipping, Bank of America, or Can Fite Biopharma?
From PR Newswire
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma
From Business Wire News Releases
Thinking about buying stock in Can Fite Biopharma, Aytu Bioscience, Hall of Fame Resort & Entertainment, Brickell Biotech, or Infinity Pharmaceuticals?
From PR Newswire
Mid-Afternoon Market Update: Crude Oil Down 1%; SunLink Health Systems Shares Spike Higher
Tags Small Cap Earnings LIZI
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback